Cargando…
Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy
Clopidogrel is the most common and widely used antiplatelet agent for patients with coronary artery disease following confirmation by electrocardiographic studies. The nonresponsiveness of patients to clopidogrel and the possibility of testing for clopidogrel resistance by platelet function assays (...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670852/ https://www.ncbi.nlm.nih.gov/pubmed/33200888 http://dx.doi.org/10.1002/prp2.686 |